A/Prof Jake Shortt appointed Deputy Chair, ALLG Scientific Advisory Committee
Associate Professor Jake Shortt from Monash Health has been appointed the new Deputy Chair of ALLG Scientific Advisory Committee (SAC).
A/Prof Shortt joins the ALLG Chair A/Prof Peter Mollee (Princess Alexandra Hospital) in leading the Scientific Advisory Committee, which acts as a steering committee for the ALLG, providing oversight for its activities and offering scientific direction for ALLG clinical trials, including the National Blood Cancer Registry (NBCR).
A/Prof Shortt is one of Australia’s leading clinician-scientists in haematology. Currently, A/Prof Shortt is the Head of Haematology Research at the School of Clinical Sciences, Monash University; Head of the Blood Cancer Therapeutics laboratory within the Monash Health Translation Precinct; and the Clinical Lead at Monash Haematology for leukaemia and myelodysplasia.
An ALLG Member since 2011, A/Prof Shortt is an astute leader and mentor within the ALLG. Having been the Chair of the ALLG Laboratory Science Working Party and serving on the Scientific Advisory Committee since 2016, he continues as a leading member of the ALLG’s Registry Operations Committee, which has the responsibility of overseeing the activities within the NBCR, Australia and New Zealand’s largest collection of real-world data regarding the clinical practice of acute myeloid leukaemia, acute lymphoblastic leukaemia and several types of uncommon lymphomas.
As Principal Investigator on several ALLG investigator-initiated trials, A/Prof Shortt’s research is wide-ranging – including leukaemia, multiple myeloma and lymphoma – with a strong focus on world-leading clinical trials and translational studies that will significantly progress clinical therapeutics for these malignancies. He is the recipient of a Medical Research Future Fund Career Development Fellowship.
On his recent appointment, A/Prof Shortt said, “I am delighted to take on this responsibility and contribute further to the terrific work the ALLG does in championing clinical research in blood cancers across Australia and New Zealand.”
Please join us in congratulating A/Prof Shortt on his appointment.